#015
After decades of failed drug trials, two new drugs have emerged in slowing memory loss associated with Alzheimer's disease: Leqembi and Donanemab. In Episode #015 I deep dive into novel Alzheimer's therapies to discuss their effectiveness, safety, and how to find out if you're at risk.
Chapters:
(0:00) Introduction
(2:00) Who's most at risk of Alzheimer's Disease?
(5:52) The Amyloid Hypothesis
(7:14) Leqembi approved by FDA
(9:16) Donanenmab may be next
(12:10) Alzheimer's drugs, brain bleeding, and death
(16:01) How do you know if you have Alzheimer's?
(21:20) Dementia and CTE
(22:49) Do taking smart drugs make us more productive? Is it worth the risk?
(27:00) The Connect - viewers' comments from previous episodes
Show Notes:
Alzheimer’s drug being tested Leqembi or Lecanemab
https://www.abc.net.au/news/2023-07-0...
Donanemab:
https://www.abc.net.au/news/2023-05-0...
Systematic failure of Alzheimer’s drug trials:
https://www.abc.net.au/news/health/20...
Are these drugs safe?
https://www.science.org/content/artic...
Symptoms of Alzheimer’s:
https://www.dementia.org.au/about-dem...
Mini Mental State Examination (MMSE)
https://cgatoolkit.ca/Uploads/Content...
CTE in female athlete:
https://theconversation.com/australia...
Smart drugs make you dumb:
https://theconversation.com/smart-dru...
Thanks for reading BioLab Collective with Jack Wang! Subscribe for free to receive new posts and support my work.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit biolabcollective.substack.com (https://biolabcollective.substack.com...)
Смотрите видео #015 онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь BioLab Collective with Jack Wang 27 Февраль 2024, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 278 раз и оно понравилось 5 людям.